BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
BMNR
Bitmine Immersion Technologies, Inc.
There isn't enough reported data to score BMNR yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BMNR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| N/A | |
| N/A |
BMNR's revenue is currently strong, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like BMNR.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
BMNR PE Valuation
BMNR has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
BMNR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for BMNR, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus BMNR down 1,036%.
BMNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.14 | — |
| Q3 2024 | -$1.40 | -$0.40 |
| Q2 2024 | -$1.40 | -$0.45 |
| Q1 2024 | -$1.40 | -$0.45 |
| Q4 2023 | -$1.20 | -$0.40 |
| Q3 2023 | -$1.00 | $0.00 |
BMNR lost $13.11 per share over the past year, a bigger loss than the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BMNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.9M | +4802% |
| Q2 2026 | $46.5M | +2168% |
| Q1 2026 | $11M | +628% |
| Q4 2025 | $2.3M | +91% |
| Q3 2025 | $1.3M | +94% |
| Q2 2025 | $2.1M | +67% |
| Q1 2025 | $1.5M | +70% |
| Q4 2024 | $1.2M | +135% |
BMNR has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4347% | -29352 points |
| Q2 2026 | -26% | -2.7 points |
| Q1 2026 | -34785% | -34725 points |
| Q4 2025 | -238565% | -238491 points |
| Q3 2025 | 33699% | +33796 points |
| Q2 2025 | -23% | +21 points |
| Q1 2025 | -60% | +13 points |
| Q4 2024 | -74% | +46 points |
BMNR has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over BMNR on cash generation, producing positive trailing cash flow while its opponent burns cash.
BMNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.6M | -$11M |
| Q2 2026 | $29M | +1629% |
| Q1 2026 | -$88.2M | -$88M |
| Q4 2025 | -$228.7M | -$228.6M |
| Q3 2025 | -$6.6M | -3106% |
| Q2 2025 | $1.7M | +$1.7M |
| Q1 2025 | -$214.2K | -$77.6K |
| Q4 2024 | -$113.9K | +$11.1K |
BMNR's free cash flow was −$306M over the past year, against −$5M the year before. Free cash flow isn't a meaningful measure for financial services companies like BMNR.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BMNR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BMNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +21% | +97.2M shares |
| 1 year | +27721% | +550M shares |
| 3 years | +25500% | +550M shares |
BMNR has 552M diluted shares, up 27721% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BMNR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.2x | Net Cash |
| Q3 2014 | 37.0x | High |
| Q1 2014 | 557.6x | High |
BMNR has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BMNR.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BMNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.3 | Neutral |
| Stochastic | 19.2 | Oversold |
BMNR's weekly RSI is 41 (neutral) and its Stochastic is 19 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BMNR PE vs Financial Services Sector
BMNR has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has stronger trend alignment. BAC is above 1 of 5 weekly averages versus BMNR above 0 of 3.
BMNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.4 | 18% below |
| 20 week MA | $20.9 | 12% below |
| 50 week MA | $22.0 | 16% below |
BMNR is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over BMNR on returns for 2026, with the stronger performance.
BMNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $15.0 | $28.3 | +89% |
| 2026 YTD | $28.3 | $18.5 | -35% |
BMNR has finished every year since 2025 higher, and it's down 35% so far in 2026.